INS and type 2 diabetes mellitus: Reduced insulin sensitivity is the pathophysiologic basis of type 2 diabetes and may underlie a host of metabolic and cardiovascular disorders including glycaemic abnormality, dyslipidemia, hypertension and abdominal adiposity, which comprise the basis of the metabolic syndrome [2].